MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
The growth hormone (GH)–insulin-like growth factor-1 (IGF1) endocrine axis is a central player in normal growth and metabolism as well as in a number of pathologies, including cancer. The GH–IGF1 hormonal system, in addition, has emerged as a major determinant of lifespan and healthspan. Laron syndr...
Main Authors: | Danielle Yaron-Saminsky, Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Metsada Pasmanik-Chor, Haim Werner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/21/11861 |
Similar Items
-
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
by: Haim Werner, et al.
Published: (2019-06-01) -
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
by: Haim Werner, et al.
Published: (2020-11-01) -
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP
by: Karthik Nagaraj, et al.
Published: (2022-10-01) -
Insulin-like growth factors and aging: lessons from Laron syndrome
by: Haim Werner, et al.
Published: (2023-10-01) -
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway
by: Rand Shibel, et al.
Published: (2021-06-01)